Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

The congress highlighted concerns about the effectiveness of over-the-counter nail treatments, the link between hair loss and daily care products, and the safety of skin treatments during COVID-19.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

People with androgenetic alopecia may have a higher risk of heart problems compared to those with alopecia areata or healthy individuals.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Secukinumab can cause hair loss, which may improve after stopping the medication.

The ILDS Newsletter reported on efforts to support albinism patients in Tanzania and dermatological conferences.

The regenerative medicine industry saw business growth with new partnerships, clinical trials, and financial investments.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.